Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer

dc.contributor.authors	Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO.
dc.date.accessioned	2020-02-27T08:41:09Z
dc.date.available	2020-02-27T08:41:09Z
dc.date.issued	2014
dc.identifier.citation	Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO. (2014). Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. Med Oncol. , 31(4, 8-905
dc.identifier.uri	https://doi.org/10.1007/s12032-014-0905-8.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66715
dc.title	Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer
dc.identifier.volume	31(4
dc.identifier.startpage	905
dc.identifier.endpage	8
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Med Oncol.
dc.identifier.doi	10.1007/s12032-014-0905-8.
dc.contributor.author	Bayoğlu, İbrahim Vedat